D-0477-2023 Class II Terminated
FDA drug recall D-0477-2023 was initiated by Direct Rx on Mar 13, 2023 and is designated Class II. Reason for recall: cGMP deviations The recall status is terminated (terminated Jun 17, 2024). Affected quantity: 19 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 5, 2023
- Initiation Date
- Mar 13, 2023
- Termination Date
- Jun 17, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19 bottles
Product description
Finasteride, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0733-90; Packaged and Distributed By: Direct Rx
Reason for recall
cGMP deviations
Distribution pattern
Nationwide in the USA
Code information
Lot, expiry: 19AU2205, exp 12/31/24; 12OC2211, exp 12/31/24
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0477-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026